The phase 1/2 trial evaluating EBT-101 dosed its first patient in September 2022.
Victoria Johnson
Advertisement
Articles by Victoria Johnson
Advertisement
Latest Updated Articles
HIV CRISPR Therapy Fast-Tracked by the FDAPublished: July 26th 2023 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Higher Acceptability of 1 Injectable in First Head-to-Head Comparison of Long-Acting PrEP
2
One Third of Chronic Hepatitis B Patients Are Lost to Follow-Up
3
Developing the Next Generation of Rifamycins for Non-TB Mycobacteria in a Post-Antibiotic Era
4
